Egetis Therapeutics AB (publ) (FRA:P0F)

Egetis Therapeutics AB Statistics

Total Valuation

FRA:P0F has a market cap or net worth of EUR 179.99 million. The enterprise value is 175.10 million.

Market Cap	179.99M
Enterprise Value	175.10M

Important Dates

The last earnings date was Tuesday, November 25, 2025.

Earnings Date	Nov 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	395.16M
Shares Outstanding	n/a
Shares Change (YoY)	+22.32%
Shares Change (QoQ)	+1.20%
Owned by Insiders (%)	10.25%
Owned by Institutions (%)	18.63%
Float	231.43M

Valuation Ratios

PE Ratio	n/a
Forward PE	18.45
PS Ratio	35.92
PB Ratio	7.17
P/TBV Ratio	7.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.81
EV / Sales	34.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.44

Financial Position

The company has a current ratio of 0.80, with a Debt / Equity ratio of 0.33.

Current Ratio	0.80
Quick Ratio	0.76
Debt / Equity	0.33
Debt / EBITDA	n/a
Debt / FCF	-0.40
Interest Coverage	-20.55

Financial Efficiency

Return on equity (ROE) is -111.83% and return on invested capital (ROIC) is -49.43%.

Return on Equity (ROE)	-111.83%
Return on Assets (ROA)	-33.74%
Return on Invested Capital (ROIC)	-49.43%
Return on Capital Employed (ROCE)	-91.03%
Revenue Per Employee	125,274
Profits Per Employee	-753,681
Employee Count	40
Asset Turnover	0.09
Inventory Turnover	45.41

Taxes

In the past 12 months, FRA:P0F has paid 27,135 in taxes.

Income Tax	27,135
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.44% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-17.44%
50-Day Moving Average	0.49
200-Day Moving Average	0.41
Relative Strength Index (RSI)	32.77
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:P0F had revenue of EUR 5.01 million and -30.15 million in losses. Loss per share was -0.08.

Revenue	5.01M
Gross Profit	1.52M
Operating Income	-28.63M
Pretax Income	-30.12M
Net Income	-30.15M
EBITDA	-26.32M
EBIT	-28.63M
Loss Per Share	-0.08

Balance Sheet

The company has 13.18 million in cash and 8.32 million in debt, giving a net cash position of 4.86 million.

Cash & Cash Equivalents	13.18M
Total Debt	8.32M
Net Cash	4.86M
Net Cash Per Share	n/a
Equity (Book Value)	25.10M
Book Value Per Share	0.07
Working Capital	-4.44M

Cash Flow

In the last 12 months, operating cash flow was -20.60 million and capital expenditures -135,676, giving a free cash flow of -20.74 million.

Operating Cash Flow	-20.60M
Capital Expenditures	-135,676
Free Cash Flow	-20.74M
FCF Per Share	n/a

Margins

Gross Margin	30.32%
Operating Margin	-571.30%
Pretax Margin	-601.08%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:P0F does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.32%
Shareholder Yield	-22.32%
Earnings Yield	-16.75%
FCF Yield	-11.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:P0F has an Altman Z-Score of -2.75 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.75
Piotroski F-Score	2